Cambridge-based bioinformatics specialist, Eagle Genomics, has been supported to raise £1m in investment through the Angels in MedCity programme; a partnership between MedCity, LBA and Angels4LifeSciences.
The investment, which included participation from the LBA EIS Roundtable Syndicate Fund 2016 and the London Co-Investment Fund (LCIF), will help Eagle Genomics to develop technology that will reduce research costs and time, and help companies get their products to market faster.